TRUIST FINANCIAL CORP - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
TRUIST FINANCIAL CORP ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,016,270
+30.2%
96,750
+49.6%
0.00%0.0%
Q2 2023$1,549,134
+85.7%
64,682
+45.9%
0.00%
+200.0%
Q1 2023$834,197
+38.7%
44,325
+17.3%
0.00%0.0%
Q4 2022$601,553
-12.2%
37,786
-9.7%
0.00%0.0%
Q3 2022$685,000
-1.6%
41,868
-15.2%
0.00%0.0%
Q2 2022$696,000
-53.2%
49,381
-19.6%
0.00%
-50.0%
Q1 2022$1,487,000
-22.6%
61,397
-25.4%
0.00%
-33.3%
Q4 2021$1,920,000
+11.2%
82,258
-20.9%
0.00%0.0%
Q3 2021$1,727,000
-18.6%
104,000
+19.5%
0.00%0.0%
Q2 2021$2,122,000
+8.8%
87,027
+15.1%
0.00%0.0%
Q1 2021$1,951,000
-14.6%
75,637
+77.0%
0.00%
-25.0%
Q4 2020$2,284,000
+88.6%
42,726
+45.5%
0.00%
+33.3%
Q3 2020$1,211,000
+52.7%
29,368
+79.4%
0.00%
+50.0%
Q2 2020$793,000
+31.1%
16,366
+14.4%
0.00%0.0%
Q1 2020$605,000
+7.8%
14,312
+9.2%
0.00%
+100.0%
Q4 2019$561,000
+155.0%
13,101
+124.5%
0.00%
-75.0%
Q3 2017$220,0005,8360.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders